Does rosuvastatin 20 mg reduce CRP and LDL cholesterol levels more effectively than atorvastatin 40 mg in patients with acute coronary syndrome?
In patients with acute coronary syndrome, a 4-week course of rosuvastatin 20 mg provides a greater reduction in the inflammatory marker CRP compared to atorvastatin 40 mg.
Both atorvastatin (40 mg) and rosuvastatin (20 mg) are effective in decreasing CRP and LDL cholesterol levels even in a short duration of 4 weeks. Rosuvastatin was found to be more effective in decreasing CRP levels.
Khurana et al. (Tue,) studied this question.